Vitrolife AB (publ) (OTCMKTS:VTRLY – Get Free Report) saw a large growth in short interest during the month of July. As of July 15th, there was short interest totaling 514 shares, a growth of 202.4% from the June 30th total of 170 shares. Based on an average daily trading volume, of 159 shares, the days-to-cover ratio is currently 3.2 days.
Vitrolife AB (publ) Stock Performance
OTCMKTS VTRLY opened at $9.50 on Wednesday. Vitrolife AB has a 52-week low of $9.50 and a 52-week high of $18.55. The company has a 50-day simple moving average of $10.45 and a 200 day simple moving average of $11.28.
Vitrolife AB (publ) Company Profile
Vitrolife AB (publ) is a Sweden‐based life science company specializing in products and systems for in vitro fertilization (IVF) and assisted reproductive technologies. Founded in 1994 and headquartered in Gothenburg, the company develops, manufactures and markets a comprehensive portfolio of consumables, culture media and instruments that support the entire IVF process, from gamete handling to embryo culture and cryopreservation.
The company’s product range includes embryo culture media, blastocyst media, vitrification solutions and pipetting tools designed to optimize laboratory workflows and improve outcomes for fertility clinics and patients.
Featured Stories
- Five stocks we like better than Vitrolife AB (publ)
- These 3 Stocks Have Soared in 2026—Can They Keep Climbing?
- Hasbro’s Earnings Beat Shows Why This Is No Longer Just a Toy Story
- Rambus: Another AI Phoenix Ready to Rise From the Ashes of Correction
- Chips & Clips: Memory Tariffs Rewire Tech Supply Chains
Receive News & Ratings for Vitrolife AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitrolife AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.
